AAAAAA

   
Results: 1-24 |
Results: 24
EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL
Authors: FONTANINI G DELAURENTIIS M VIGNATI S CHINE S LUCCHI M SILVESTRI V MUSSI A DEPLACIDO S TORTORA G BIANCO AR GULLICK W ANGELETTI CA BEVILACQUA G CIARDIELLO F
Citation: G. Fontanini et al., EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL, Clinical cancer research, 4(1), 1998, pp. 241-249
EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL
Authors: FONTANINI G DELAURENTIIS M VIGNATI S CHINE S LUCCHI M SILVESTRI V MUSSI A DEPLACIDO S TORTORA G BIANCO AR GULLICK W ANGELETTI CA BEVILACQUA G CIARDIELLO F
Citation: G. Fontanini et al., EVALUATION OF EPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTORS AND RECEPTORS AND OF NEOANGIOGENESIS IN COMPLETELY RESECTED STAGE I-IIIA NON-SMALL-CELL LUNG-CANCER - AMPHIREGULIN AND MICROVESSEL COUNT ARE INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL, Clinical cancer research, 4(1), 1998, pp. 241-249
15 YEAR UPDATE OF THE NAPLES GUN TRIAL OF ADJUVANT BREAST-CANCER THERAPY - EVIDENCE OF INTERACTION BETWEEN C-ERB-B2 EXPRESSION AND TAMOXIFEN EFFICACY
Authors: BIANCO AR DELAURENTIIS M CARLOMAGNO C LAURIA R PETRELLA G PANICO L PETTINATO G PERRONE F GALLO C MARINELLI A DEPLACIDO S
Citation: Ar. Bianco et al., 15 YEAR UPDATE OF THE NAPLES GUN TRIAL OF ADJUVANT BREAST-CANCER THERAPY - EVIDENCE OF INTERACTION BETWEEN C-ERB-B2 EXPRESSION AND TAMOXIFEN EFFICACY, European journal of cancer, 34, 1998, pp. 46-46
ANGIOGENESIS AS A PROGNOSTIC INDICATOR OF SURVIVAL IN NON-SMALL-CELL LUNG-CARCINOMA - A PROSPECTIVE-STUDY
Authors: FONTANINI G LUCCHI M VIGNATI S MUSSI A CIARDIELLO F DELAURENTIIS M DEPLACIDO S BASOLO F ANGELETTI CA BEVILACQUA G
Citation: G. Fontanini et al., ANGIOGENESIS AS A PROGNOSTIC INDICATOR OF SURVIVAL IN NON-SMALL-CELL LUNG-CARCINOMA - A PROSPECTIVE-STUDY, Journal of the National Cancer Institute, 89(12), 1997, pp. 881-886
ANTITUMOR-ACTIVITY OF COMBINED BLOCKADE OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND PROTEIN-KINASE-A
Authors: CIARDIELLO F DAMIANO V BIANCO R BIANCO C FONTANINI G DELAURENTIIS M DEPLACIDO S MENDELSOHN J BIANCO AR TORTORA G
Citation: F. Ciardiello et al., ANTITUMOR-ACTIVITY OF COMBINED BLOCKADE OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND PROTEIN-KINASE-A, Journal of the National Cancer Institute, 88(23), 1996, pp. 1770-1776
ALPHA-INTERFERON POTENTIATES THE GROWTH-INHIBITORY EFFECTS OF ANTITRANSFERRIN RECEPTOR MONOCLONAL-ANTIBODIES
Authors: CARAGLIA M LEARDI A RICCIARDI B DELAURENTIIS M GRAZIANO MLL MATANO E DEPLACIDO S BIANCO AR TAGLIAFERRI P
Citation: M. Caraglia et al., ALPHA-INTERFERON POTENTIATES THE GROWTH-INHIBITORY EFFECTS OF ANTITRANSFERRIN RECEPTOR MONOCLONAL-ANTIBODIES, International journal of oncology, 8(5), 1996, pp. 847-850
SELECTING HIGH-RISK EARLY BREAST-CANCER PATIENTS - WHAT TO ADD TO THENUMBER OF METASTATIC NODES
Authors: PERRONE F CARLOMAGNO C LAURIA R DELAURENTIIS M MORABITO A PANICO L PETTINATO G PETRELLA G GALLO C BIANCO AR DEPLACIDO S
Citation: F. Perrone et al., SELECTING HIGH-RISK EARLY BREAST-CANCER PATIENTS - WHAT TO ADD TO THENUMBER OF METASTATIC NODES, European journal of cancer, 32A(1), 1996, pp. 41-46
C-ERBB2 OVEREXPRESSION DECREASES THE BENEFIT OF ADJUVANT TAMOXIFEN INEARLY-STAGE BREAST-CANCER WITHOUT AXILLARY LYMPH-NODE METASTASES
Authors: CARLOMAGNO C PERRONE F GALLO C DELAURENTIIS M LAURIA R MORABITO A PETTINATO G PANICO L DANTONIO A BIANCO AR DEPLACIDO S
Citation: C. Carlomagno et al., C-ERBB2 OVEREXPRESSION DECREASES THE BENEFIT OF ADJUVANT TAMOXIFEN INEARLY-STAGE BREAST-CANCER WITHOUT AXILLARY LYMPH-NODE METASTASES, Journal of clinical oncology, 14(10), 1996, pp. 2702-2708
PROGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: CATALANO L IMPROTA S DELAURENTIIS M MOLICA S MAJOLINO I MUSTO P FRAGASSO A DEPLACIDO S ROTOLI B
Citation: L. Catalano et al., PROGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA, Haematologica, 81(4), 1996, pp. 324-329
DIFFERENTIAL IMMUNOHISTOCHEMICAL DETECTION OF TRANSFORMING GROWTH-FACTOR-ALPHA, AMPHIREGULIN AND CRIPTO IN HUMAN NORMAL AND MALIGNANT BREAST TISSUES
Authors: PANICO L DANTONIO A SALVATORE G MEZZA E TORTORA G DELAURENTIIS M DEPLACIDO S GIORDANO T MERINO M SALOMON DS GULLICK WJ PETTINATO G SCHNITT SJ BIANCO AR CIARDIELLO F
Citation: L. Panico et al., DIFFERENTIAL IMMUNOHISTOCHEMICAL DETECTION OF TRANSFORMING GROWTH-FACTOR-ALPHA, AMPHIREGULIN AND CRIPTO IN HUMAN NORMAL AND MALIGNANT BREAST TISSUES, International journal of cancer, 65(1), 1996, pp. 51-56
A PREDICTIVE INDEX OF AXILLARY NODAL INVOLVEMENT IN OPERABLE BREAST-CANCER
Authors: DELAURENTIIS M GALLO C DEPLACIDO S PERRONE F PETTINATO G PETRELLA G CARLOMAGNO C PANICO L DELRIO P BIANCO AR
Citation: M. Delaurentiis et al., A PREDICTIVE INDEX OF AXILLARY NODAL INVOLVEMENT IN OPERABLE BREAST-CANCER, British Journal of Cancer, 73(10), 1996, pp. 1241-1247
DNA-FLOW CYTOMETRY (PLOIDY AND S-PHASE FRACTION) AS PROGNOSTIC FACTORIN A RETROSPECTIVE SERIES OF 515 PRIMARY BREAST-CANCER
Authors: PEPE S RUGGIERO A DELAURENTIIS M NORMANNO N FIORENTINO B PERRONE F CARLOMAGNO C DEPLACIDO S PANICO L PETTINATO G BORRIELLO G BIANCO AR
Citation: S. Pepe et al., DNA-FLOW CYTOMETRY (PLOIDY AND S-PHASE FRACTION) AS PROGNOSTIC FACTORIN A RETROSPECTIVE SERIES OF 515 PRIMARY BREAST-CANCER, Oncology Reports, 2(3), 1995, pp. 345-350
MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION
Authors: TAGLIAFERRI P MATANO E REA A FAMIANI M CIARDIELLO F TORTORA G MONTESARCHIO V MORABITO A CARAGLIA M DELAURENTIIS M DEPLACIDO S PALMIERI G BIANCO AR
Citation: P. Tagliaferri et al., MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION, Oncology Reports, 2(3), 1995, pp. 365-368
ERBB2 OVEREXPRESSION AFFECTS TAMOXIFEN EFFICACY IN THE ADJUVANT TREATMENT OF NODE-NEGATIVE OPERABLE BREAST-CANCER PATIENTS
Authors: CARLOMAGNO C PERRONE F LAURIA R DELAURENTIIS M GALLO C MORABITO A PETTINATO G PANICO L DEPLACIDO S BIANCO AR
Citation: C. Carlomagno et al., ERBB2 OVEREXPRESSION AFFECTS TAMOXIFEN EFFICACY IN THE ADJUVANT TREATMENT OF NODE-NEGATIVE OPERABLE BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 45-45
PROGNOSTIC-SIGNIFICANCE OF NECROSIS, ELASTOSIS, FIBROSIS AND INFLAMMATORY CELL REACTION IN OPERABLE BREAST-CANCER
Authors: CARLOMAGNO C PERRONE F LAURIA R DELAURENTIIS M GALLO C MORABITO A PETTINATO G PANICO L BELLELLI T APICELLA A PETRELLA G BIANCO AR DEPLACIDO S
Citation: C. Carlomagno et al., PROGNOSTIC-SIGNIFICANCE OF NECROSIS, ELASTOSIS, FIBROSIS AND INFLAMMATORY CELL REACTION IN OPERABLE BREAST-CANCER, Oncology, 52(4), 1995, pp. 272-277
THE PROGNOSTIC VALUE OF LYMPHATIC AND BLOOD-VESSEL INVASION IN OPERABLE BREAST-CANCER
Authors: LAURIA R PERRONE F CARLOMAGNO C DELAURENTIIS M MORABITO A GALLO C VARRIALE E PETTINATO G PANICO L PETRELLA G BIANCO AR DEPLACIDO S
Citation: R. Lauria et al., THE PROGNOSTIC VALUE OF LYMPHATIC AND BLOOD-VESSEL INVASION IN OPERABLE BREAST-CANCER, Cancer, 76(10), 1995, pp. 1772-1778
CMF VS ALTERNATING CMF EV IN THE ADJUVANT TREATMENT OF OPERABLE BREAST-CANCER - A SINGLE-CENTER RANDOMIZED CLINICAL-TRIAL (NAPLES GUN-3 STUDY)/
Authors: DEPLACIDO S PERRONE F CARLOMAGNO C MORABITO A PAGLIARULO C LAURIA R MARINELLI A DELAURENTIIS M VARRIALE E PETRELLA G GALLO C BIANCO AR
Citation: S. Deplacido et al., CMF VS ALTERNATING CMF EV IN THE ADJUVANT TREATMENT OF OPERABLE BREAST-CANCER - A SINGLE-CENTER RANDOMIZED CLINICAL-TRIAL (NAPLES GUN-3 STUDY)/, British Journal of Cancer, 71(6), 1995, pp. 1283-1287
PREDICTION OF AXILLARY LYMPH-NODE STATUS IN BREAST-CANCER PATIENTS BYUSE OF PROGNOSTIC INDICATORS
Authors: RAVDIN PM DELAURENTIIS M VENDELY T CLARK GM
Citation: Pm. Ravdin et al., PREDICTION OF AXILLARY LYMPH-NODE STATUS IN BREAST-CANCER PATIENTS BYUSE OF PROGNOSTIC INDICATORS, Journal of the National Cancer Institute, 86(23), 1994, pp. 1771-1775
PROGNOSTIC-SIGNIFICANCE OF MULTIFOCALITY IN PRIMARY BREAST-CANCER
Authors: MORABITO A PERRONE F LAURIA R CARLOMAGNO C MARINELLI A DELAURENTIIS M MARTIGNETTI A PETTINATO G PANICO L PETRELLA G GALLO C BIANCO AR DEPLACIDO S
Citation: A. Morabito et al., PROGNOSTIC-SIGNIFICANCE OF MULTIFOCALITY IN PRIMARY BREAST-CANCER, Oncology Reports, 1(6), 1994, pp. 1045-1048
A TECHNIQUE FOR USING NEURAL-NETWORK ANALYSIS TO PERFORM SURVIVAL ANALYSIS OF CENSORED-DATA
Authors: DELAURENTIIS M RAVDIN PM
Citation: M. Delaurentiis et Pm. Ravdin, A TECHNIQUE FOR USING NEURAL-NETWORK ANALYSIS TO PERFORM SURVIVAL ANALYSIS OF CENSORED-DATA, Cancer letters, 77(2-3), 1994, pp. 127-138
MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY
Authors: PERRONE F DEPLACIDO S CARLOMAGNO C GRAVINA A DELAURENTIIS M DELMASTRO L GRIDELLI C PAGLIARULO C BIANCO AR
Citation: F. Perrone et al., MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY, American journal of clinical oncology, 17(3), 1994, pp. 218-222
PROGNOSTIC FACTORS - RATIONALE AND METHODS OF ANALYSIS AND INTEGRATION
Authors: CLARK GM HILSENBECK SG RAVDIN PM DELAURENTIIS M OSBORNE CK
Citation: Gm. Clark et al., PROGNOSTIC FACTORS - RATIONALE AND METHODS OF ANALYSIS AND INTEGRATION, Breast cancer research and treatment, 32(1), 1994, pp. 105-112
SURVIVAL ANALYSIS OF CENSORED-DATA - NEURAL-NETWORK ANALYSIS DETECTION OF COMPLEX INTERACTIONS BETWEEN VARIABLES
Authors: DELAURENTIIS M RAVDIN PM
Citation: M. Delaurentiis et Pm. Ravdin, SURVIVAL ANALYSIS OF CENSORED-DATA - NEURAL-NETWORK ANALYSIS DETECTION OF COMPLEX INTERACTIONS BETWEEN VARIABLES, Breast cancer research and treatment, 32(1), 1994, pp. 113-118
CHEMOTHERAPY WITH MITOMYCIN-C AND VINBLASTINE IN PRETREATED METASTATIC BREAST-CANCER
Authors: PERRONE F DEPLACIDO S CARLOMAGNO C NUZZO F RUGGIERO A DELAURENTIIS M GRIDELLI C PAGLIARULO C BIANCO AR
Citation: F. Perrone et al., CHEMOTHERAPY WITH MITOMYCIN-C AND VINBLASTINE IN PRETREATED METASTATIC BREAST-CANCER, Tumori, 79(4), 1993, pp. 254-257
Risultati: 1-24 |